Interference By Venlafaxine Ingestion in the Detection of Tramadol By Liquid Chromatography Linked to Tandem Mass Spectrometry for the Screening of Illicit Drugs in Human Urine

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Clinical toxicology

• Publication date

  2006-01-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1080/15563650500514434PMID 16615670
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Confirmatory analysis for drugs of abuse in plasma and urine by high-performance liquid chromatography-tandem mass spectrometry with respect to criteria for compound identification.

  2004cited by this paper
• Multicomponent Screening for Drugs of Abuse: Direct Analysis of Urine by LC-MS-MS

  2004cited by this paper
• Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies.

  2003cited by this paper
• Urine drug testing for opioids, cocaine, and metabolites by direct injection liquid chromatography/tandem mass spectrometry.

  2003cited by this paper
• Simultaneous screening for 238 drugs in blood by liquid chromatography-ion spray tandem mass spectrometry with multiple-reaction monitoring.

  2003cited by this paper

• Evaluation of the detuning ratio as a tool to detect potential interference in LC-MSMS analysis

  2025cites this paper
• Automated and Fully Validated High‐Throughput LC‐MS/MS Assay for Analyzing Multiple Drugs of Abuse in Oral Fluids Using Novel Features in Sample Preparation and Chromatographic Conditions

  2025cites this paper
• Understanding isotopes, isomers, and isobars in mass spectrometry

  2024cites this paper
• The use of deep eutectic solvent-liquid phase microextraction as green analytical sample treatment for the analysis of drugs in urine

  2024cites this paper
• False Positive Tramadol Urine Testing in Patients Taking Fexofenadine: A Tale of Two Consecutive Cases

  2023cites this paper
• Collision cross section measurement and prediction methods in omics.

  2023cites this paper
• Is pain temporary and glory for ever? Detection of tramadol using dried blood spot in cycling competitions.

  2020cites this paper
• Determination of citalopram in fish brain tissue: benefits of coupling laser diode thermal desorption with low- and high-resolution mass spectrometry

  2020cites this paper
• Approaches to drug monitoring: partnering with the clinical laboratory.

  2020cites this paper
• A Review on LC-MS Method to Determine Antipsychotic Drugs in Biological Samples

  2020cites this paper
• Pitfalls in drug testing by hyphenated low- and high-resolution mass spectrometry.

  2019cites this paper
• ACUTE VENLAFAXINE OVERDOSE WITH POSITIVE URINE IMMUNOASSAY FOR TRAMADOL – CLINICAL AND DIAGNOSTIC OVERLAP - CASE REPORT AND LITERATURE OVERVIEW

  2019cites this paper
• Current and future directions of high resolution and tandem mass spectrometry in postmortem and human performance toxicology.

  2019cites this paper
• Validation of a simple, fast liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of 40 antidepressant drugs or their metabolites in plasma.

  2018cites this paper
• A multi-analyte approach to help in assessing the severity of acute poisonings - Development and validation of a fast LC-MS/MS quantification approach for 45 drugs and their relevant metabolites with one-point calibration.

  2018cites this paper
• Identification of Novel Opioid Interferences using High-Resolution Mass Spectrometry.

  2018cites this paper
• Interference Testing and Isobaric Compounds: Is Your Mass Spectrometry-based Assay as Good as You Think It Is?

  2018cites this paper
• Matrix effect management in liquid chromatography mass spectrometry: the internal standard normalized matrix effect.

  2017cites this paper
• LC-MS/MS as a tool for TDM services: Where are we?

  2016cites this paper
• Development and validation of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) procedure for screening of urine specimens for 100 analytes relevant in drug-facilitated crime (DFC)

  2014cites this paper
• Toxicological Analysis: Drug Screening and Confirmation

  2014cites this paper
• Simultaneous quantification of amphetamine, opiates, ketamine and relative metabolites in urine for confirmatory analysis by liquid chromatography tandem mass spectrometry.

  2013cites this paper
• Quantitative mass spectrometry-based assay development and validation: from small molecules to proteins.

  2013cites this paper
• Quantification of 31 illicit and medicinal drugs and metabolites in whole blood by fully automated solid-phase extraction and ultra-performance liquid chromatography–tandem mass spectrometry

  2013cites this paper
• What is the future of (ultra) high performance liquid chromatography coupled to low and high resolution mass spectrometry for toxicological drug screening?

  2013cites this paper
• Development and validation of a sensitive UPLC-MS/MS method for the analysis of narcotic analgesics in urine and whole blood in forensic context.

  2012cites this paper
• Influence of CYP2D6 genotype on the disposition of the enantiomers of venlafaxine and its major metabolites in postmortem femoral blood.

  2012cites this paper
• Method development for pharmaceutics: some solutions for tuning selectivity in reversed phase and hydrophilic interaction liquid chromatography.

  2012cites this paper
• An introduction to drug testing: the expanding role of mass spectrometry.

  2012cites this paper
• SEIZURES AFTER USE AND ABUSE OF

  2012cites this paper
• Identification and validated quantification of drugs of abuse, medicaments and their metabolites in blood and hair using liquid chromatographic : tandem mass spectrometric techniques in forensic toxicology and therapeutic drug monitoring

  2012cites this paper
• Pitfalls of LC-MS/MS in the Clinical Laboratory

  2012cites this paper
• Identification and validated quantification of drugs of abuse , medicaments and their metabolites in blood and hair using liquid chromatographic – tandem mass spectrometric techniques in forensic toxicology and therapeutic drug monitoring

  2012cites this paper
• The analysis of antipsychotic drugs in human matrices using LC-MS(/MS).

  2012cites this paper
• A multi-target screening analysis in human plasma using fast liquid chromatography-hybrid tandem mass spectrometry (Part II).

  2011cites this paper
• A multi-target screening analysis in human plasma using fast liquid chromatography-hybrid tandem mass spectrometry (Part I).

  2011cites this paper
• Fragmentation of toxicologically relevant drugs in positive-ion liquid chromatography-tandem mass spectrometry.

  2011cites this paper
• LC-MS in analytical toxicology: some practical considerations.

  2011cites this paper
• Examining the use of tramadol hydrochloride as an antidepressant.

  2011influential citation
• Quantification of antidepressants and antipsychotics in human serum by precipitation and ultra high pressure liquid chromatography-tandem mass spectrometry.

  2011cites this paper
• Determination of 19 drugs of abuse and metabolites in whole blood by high-performance liquid chromatography–tandem mass spectrometry

  2010cites this paper
• Differentiation of structural isomers in a target drug database by LC/Q-TOFMS using fragmentation prediction.

  2010cites this paper
• Measurement of benzodiazepines in urine by liquid chromatography-tandem mass spectrometry: confirmation of samples screened by immunoassay

  2010cites this paper
• Neonatal Hair Analysis by Liquid Chromatography-High-Resolution Mass Spectrometry to Reveal Gestational Exposure to Venlafaxine

  2010cites this paper
• confirmation of samples screened by immunoassay Measurement of benzodiazepines in urine by liquid chromatography-tandem mass spectrometry :

  2010cites this paper
• Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory.

  2010cites this paper
• Perspectives of Liquid Chromatography Coupled to Low- and High-Resolution Mass Spectrometry for Screening, Identification, and Quantification of Drugs in Clinical and Forensic Toxicology

  2010cites this paper
• High-throughput simultaneous analysis of buprenorphine, methadone, cocaine, opiates, nicotine, and metabolites in oral fluid by liquid chromatography tandem mass spectrometry

  2010cites this paper
• Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women.

  2010cites this paper
• Criteria for opiate identification using liquid chromatography linked to tandem mass spectrometry: problems in routine practice

  2009cites this paper
• Tramadol: seizures, serotonin syndrome, and coadministered antidepressants.

  2009cites this paper
• Applications of ultra performance liquid chromatography (UPLC) and tandem mass spectrometry for the detection and quantification of cocaine, amphetamine, and opiate derivatives in human meconium

  2009cites this paper
• 'False-positive' and 'false-negative' test results in clinical urine drug testing.

  2009cites this paper
• Evaluation of tramadol and its main metabolites in horse plasma by high-performance liquid chromatography/fluorescence and liquid chromatography/electrospray ionization tandem mass spectrometry techniques.

  2009cites this paper
• Direct injection LC-MS/MS method for identification and quantification of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in urine drug testing.

  2008cites this paper
• Mixed-mode stationary phases as a complementary selectivity concept in liquid chromatography–tandem mass spectrometry-based bioanalytical assays

  2008cites this paper
• Chapter 19 Drugs and driving

  2008cites this paper
• Succinylmonocholine analytics as an example for selectivity problems in high-performance liquid chromatography/tandem mass spectrometry, and resulting implications for analytical toxicology.

  2008cites this paper
• Pitfalls and prevention strategies for liquid chromatography-tandem mass spectrometry in the selected reaction-monitoring mode for drug analysis.

  2008influential citation
• Forensic science.

  2007cites this paper
• Current role of liquid chromatography–mass spectrometry in clinical and forensic toxicology

  2007cites this paper
• Current role of LC-MS in therapeutic drug monitoring

  2007cites this paper
• Current literature in mass spectrometry.

  2006cites this paper